DFTX Definium Therapeutics, Inc.
Healthcare$22.50-0.66%ClosedMarket Cap: $2.45B
As of 2026-05-25
Analyst Consensus
Consensus
Buy
Target (Consensus)
$35.50
Target (Median)
$36.50
Target Range
$25.00 - $48.00
Upside from current price: 57.8%
Rating Distribution
4 Strong Buy12 Buy0 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-08 | Piper Sandler | maintain | Overweight | Overweight |
| 2026-04-22 | Leerink Partners | maintain | Outperform | Outperform |
| 2026-04-16 | Canaccord Genuity | maintain | Buy | Buy |
| 2026-03-02 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-01-23 | RBC Capital | maintain | Outperform | Outperform |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-1.66 | $47.4M | 10 |
| Sun Dec 31 | $-0.69 | $205.3M | 11 |
| Mon Dec 31 | $0.93 | $496.5M | 4 |
| Tue Dec 31 | $2.99 | $839.9M | 4 |